September 09, 2013
Under a recent appointment, a CHOC physician will help the federal government evaluate the safety of drugs used for infectious disease treatment.
Dr. Antonio Arrieta, CHOC’s director of pediatric infectious diseases and director of infectious disease clinical research, has been named a member of the Anti-Infective Drugs Advisory Committee of the Food and Drug Administration.
“I was really honored to be asked, and I was happy to say yes,” he said.
In his new role, Dr. Arrieta will review and evaluate data surrounding the safety and effectiveness of human drug products for use in the treatment of infectious diseases and related disorders. Dr. Arrieta’s term will last through November 2015.
“The committee evaluates data from clinical trials and makes recommendations regarding the safety and efficacy of new products,” he said.
Members of the 13-seat committee are selected among individuals knowledgeable in the fields of infectious disease, internal medicine, microbiology, pediatrics, epidemiology or statistics, and related specialties.
Dr. Arrieta has been at CHOC since 1991. He specializes in the treatment of serious community-acquired and nosocomial infections and has added expertise in HIV medicine. He completed his fellowship at UCI-Memorial/Miller Children's Hospital in Long Beach. He did his residency at Southern Illinois University in Springfield, Ill.
More information about Dr. Arrieta is available here.
About CHOC Children's: Named one of the best children’s hospitals by U.S. News & World Report (2014-2015) and a 2013 Leapfrog Top Hospital, CHOC Children's is exclusively committed to the health and well-being of children through clinical expertise, advocacy, outreach and research that brings advanced treatment to pediatric patients. Affiliated with the University of California, Irvine, CHOC’s regional health care network includes two state-of-the-art hospitals in Orange and Mission Viejo, several primary and specialty care clinics, a pediatric residency program, and four centers of excellence - The CHOC Children’s Heart, Neuroscience, Orthopaedic and Hyundai Cancer Institutes. CHOC earned the Gold Level CAPE Award from the California Council of Excellence, the only children’s hospital in California to ever earn this distinction, and was awarded Magnet designation, the highest honor bestowed to hospitals for nursing excellence. Recognized for extraordinary commitment to high-quality critical care standards, CHOC’s Pediatric Intensive Care Unit (PICU) is the first in the United States to earn the Pediatric Beacon Award for Critical Care Excellence.
Andrea Woodhouse, Public Relations Specialist
phone: (714) 509-4183